Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
Clinical trial NCT00789828 · COMPLETED
Trial details
- NCT number
- NCT00789828
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2011-03-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.